Company Profile

Auritec Pharmaceuticals LLC (AKA: Auritec Pharma~Auritec Pharmaceuticals LLC)
Profile last edited on: 4/30/2018      CAGE: 414W4      UEI: QX8KP6JKQ2L8

Business Identifier: Sustained Release Drug Delivery
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1512 11th Street Suite 203
Santa Monica, CA 90401
   (310) 434-0185
Location: Multiple
Congr. District: 36
County: Los Angeles

Public Profile

Auritec Pharmaceuticals LLC is developing extended release drug delivery systems, with applications in treating a variety of life-threatening diseases. The company's proprietary Plexis technology combines a membrane-based, diffusion-driven release mechanism with drug particle sizing large enough to allow high drug loading but small enough to be injected. Auritec's Versa platform involves a core of a solid drug coated with a semi-permeable polymer-targeted and sustained drug delivery system. The Plexis platform may be used in the treatment of schizophrenia, Alzheimer’s, graft rejection, arthritis, macular edema and HIV. Auritec’s Versa platform utilizes the technology behind the FDA approved Vitrasert and Retisert for sustained release implants of a wide range of solubilities over the timescale of months to years.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Gary Ransom -- Board Member and former CEO

  Thomas J Smith -- Chairman ; Chief Executive Officer

  Meredith Blake

  Amanda Malone -- VP and COO

  John Moss

  Lisa Portscher

  William H Slattery

  Sally J Smith

  Robyn Willis -- Director of Regulatory Affairs and Preclinical Development